Clinical trial signals exist, and they deserve context: Sleep Recovery, 2024 documents that in a clinical trial, 7% of patients taking Wegovy reported insomnia as a side effect, a finding that suggests a measurable signal in controlled study conditions, yet does not prove causation for everyone taking the drug
Focus on maintaining strength and intensity rather than increasing volume
Semaglutide for weight loss what you need to know Cleveland Clinic (2024)
this finding was not observed with dulaglutide, suggesting that the adherence rates for semaglutide QW are more consistent over time compared with the adherence rates for dulaglutide
Sobos approach is especially relevant
This may explain why tirzepatide, despite producing greater weight loss than semaglutide, actually shows lower rates of nausea